Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level

BACKGROUND: The availability of molecular-targeted therapies for the treatment of melanoma has emphasised the need to identify mutations in target genes such as BRAF and KIT. Circulating tumour cells (CTC) are present in the peripheral blood of a significant proportion of cancer patients. METHODS: H...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaizawa, K, Goto, Y, Kiniwa, Y, Uchiyama, A, Harada, K, Shimada, S, Saida, T, Ferrone, S, Takata, M, Uhara, H, Okuyama, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305957/
https://www.ncbi.nlm.nih.gov/pubmed/22281663
http://dx.doi.org/10.1038/bjc.2012.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305957/
https://www.ncbi.nlm.nih.gov/pubmed/22281663
http://dx.doi.org/10.1038/bjc.2012.12

Ejemplares similares